Skip to main content

Research Repository

Advanced Search

The characteristics and prognostic significance of histone H1 expression in breast cancer

Lashen, Ayat G.; Almalki, Nabeelah; Toss, Michael; Mirza, Sameer; Malki, Mohammed Imad; Rutland, Catrin S.; Jeyapalan, Jennie N.; Green, Andrew R.; Mongan, Nigel P.; Madhusudan, Srinivasan; Rakha, Emad A.

Authors

Ayat G. Lashen

Nabeelah Almalki

Michael Toss

Sameer Mirza

Mohammed Imad Malki

CATRIN RUTLAND CATRIN.RUTLAND@NOTTINGHAM.AC.UK
Professor of Molecular Medicine

NIGEL MONGAN nigel.mongan@nottingham.ac.uk
Associate Pro-Vice Chancellorglobal Engagement

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology



Abstract

Histone H1 (H.H1) is involved in chromatin organisation and gene regulation and is overexpressed in many malignant tumours, including breast cancer (BC). This study proposed and evaluated the prognostic role of H.H1 expression in BC.

H.H1 mRNA expression was evaluated in publicly available BC dataset bc-GenExMiner database (n=4421). H.H1 protein expression was assessed immunohistochemically in a well-characterised early-stage BC cohort (n=1311), and associations with clinicopathological data and survival outcomes were evaluated.

At the mRNA level, there was a significant association between high H.H1 mRNA and basal-like BC subtype and with poor outcome. The association with shorter survival was observed in the whole cohort and in the basal-like class. H.H1 protein expression was detected in both tumour cells and surrounding stroma. Total expression was detected in 72% of the cases including 28% in tumour cell nuclei and 44% in the stroma. There was strong association between high tumour H.H1 expression and triple-negative BC (TNBC) subtype (p=0.007) and with shorter survival (p=0.019), independent of other variables including tumour size, histologic tumour grade, and lymph node status.

H.H1 expression is associated with poor prognosis in BC. Given poor prognostic role of H.H1 in TNBC, it may represent a potential therapeutic target for patients with this aggressive disease.

Citation

Lashen, A. G., Almalki, N., Toss, M., Mirza, S., Malki, M. I., Rutland, C. S., Jeyapalan, J. N., Green, A. R., Mongan, N. P., Madhusudan, S., & Rakha, E. A. (2024). The characteristics and prognostic significance of histone H1 expression in breast cancer. Pathology, 56(6), 826-833. https://doi.org/10.1016/j.pathol.2024.03.012

Journal Article Type Article
Acceptance Date Mar 27, 2024
Online Publication Date Jun 8, 2024
Publication Date 2024-10
Deposit Date Apr 12, 2024
Publicly Available Date Jun 9, 2025
Journal Pathology
Print ISSN 0031-3025
Electronic ISSN 1465-3931
Publisher Lippincott, Williams & Wilkins
Peer Reviewed Peer Reviewed
Volume 56
Issue 6
Pages 826-833
DOI https://doi.org/10.1016/j.pathol.2024.03.012
Keywords Breast cancer; histone H1; endocrine; prognosis; molecular classes
Public URL https://nottingham-repository.worktribe.com/output/33565822
Publisher URL https://www.sciencedirect.com/science/article/abs/pii/S0031302524001430